| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/07/2005 | EP0738328B1 Composition containing nucleic acids, preparation and uses |
| 12/07/2005 | EP0724589B1 A method for enhancing neurone survival and agents useful for same |
| 12/07/2005 | EP0697893B1 Neural thread protein gene expression and detection of alzheimer's disease |
| 12/07/2005 | EP0694080B1 Diagnosis and treatment of supravalvular aortic stenosis |
| 12/07/2005 | CN1705747A Vector for anti-HPV vaccine and transformed microorganism by the vector |
| 12/07/2005 | CN1705682A Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes |
| 12/07/2005 | CN1705670A 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles |
| 12/07/2005 | CN1705654A Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl-and didesmethyl-metabolites of citalopram |
| 12/07/2005 | CN1705649A Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 12/07/2005 | CN1705647A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/07/2005 | CN1705644A Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 12/07/2005 | CN1705494A Colon cleansing compositions and methods |
| 12/07/2005 | CN1705488A Dengue virus infection inhibitor |
| 12/07/2005 | CN1705487A Carbohydrate based anti-bacterials |
| 12/07/2005 | CN1705486A Bisphosphonates for the treatment of antheroscleorosis and devices comprising them |
| 12/07/2005 | CN1705485A Method of adminstering bisphosphonates |
| 12/07/2005 | CN1705484A Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| 12/07/2005 | CN1705483A Prolonged release pharmaceutical composition |
| 12/07/2005 | CN1705482A Transdermal patch for external use comprising fentanyl |
| 12/07/2005 | CN1705481A Preparation of triazospiro compounds |
| 12/07/2005 | CN1705479A Distrontium 2-(n,n-di(carboxymethyl)amino)-3-cyano-4-carboxymethyl thiophene-5-carboxylate are used to reduce gastro-duodenal pain |
| 12/07/2005 | CN1705478A Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 12/07/2005 | CN1705477A Pharmaceutical composition for treating pain comprising oxicarbazepine, or derivatives thereof, and COX2 inhibitors |
| 12/07/2005 | CN1705476A Enhancement of alcohol metabolism |
| 12/07/2005 | CN1705475A A method of treating vasomotor symptoms comprising a compound having norepinephrine reuptake inhibitor activity and 5-HT2A antagonistic activity |
| 12/07/2005 | CN1705474A Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| 12/07/2005 | CN1705473A Chromones and chromone derivatives and uses thereof |
| 12/07/2005 | CN1705472A Transdermal drug delivery system with improved water absorbability and adhesion properties |
| 12/07/2005 | CN1705471A Deferacirox dispersible tablets |
| 12/07/2005 | CN1704417A Novel curcumenol derivatives |
| 12/07/2005 | CN1704404A Tricyclic protein kinase inhibitors |
| 12/07/2005 | CN1704121A Anti-angiogenic compositions and methods of use |
| 12/07/2005 | CN1704114A Synergistic antiplaque antigingivitis oral composition |
| 12/07/2005 | CN1704066A Pharmaceutical use of isolarisiresinol |
| 12/07/2005 | CN1704065A Pharmaceutical use of hesperidin and/or naringin |
| 12/07/2005 | CN1704064A Novel uses of polyhydroxy gallic acyl-beta-D-glucose derivatives |
| 12/07/2005 | CN1704063A Novel use of ursodesoxycholic acid |
| 12/07/2005 | CN1704062A Sustained release tablet of oleanolic acid and its preparation method |
| 12/07/2005 | CN1704061A Orally disintegrating tablet of oleanolic acid and its preparation process |
| 12/07/2005 | CN1704060A Compound sodium houttuyfonate |
| 12/07/2005 | CN1704059A Orally disintegrating tablet of rotundine and its preparation method |
| 12/07/2005 | CN1704058A Sustained releasing capsule of rotundine and its preparation method |
| 12/07/2005 | CN1704057A Method for preparing lomefloxacin hydrochloride for injection |
| 12/07/2005 | CN1704056A Compound preparation for resisting Parkinson's disease |
| 12/07/2005 | CN1704055A Compound preparation for resisting senile dementia |
| 12/07/2005 | CN1704054A Dispersible tablet of acetazolamide and its preparation method |
| 12/07/2005 | CN1704053A Aseptic subpackage preparation of tindazole for injection |
| 12/07/2005 | CN1704052A Method for preparing enalapril for injection |
| 12/07/2005 | CN1704051A Novel use of chromene compound |
| 12/07/2005 | CN1704050A Pharmaceutical use of 5-hydroxymethyl furfural |
| 12/07/2005 | CN1704049A Stable solution containing tiopronin for injection |
| 12/07/2005 | CN1704048A Compound calcium phenolsulfonic acid |
| 12/07/2005 | CN1704047A Novel use of formaldehyde in preparation of drug for animals |
| 12/07/2005 | CN1230538C Immunological reagent specifically interreacting with the extracellular domain of the human zeta chain |
| 12/07/2005 | CN1230508C Stable N-carbanilide composition |
| 12/07/2005 | CN1230449C Heparin-derived polysaccharide mixtures, prepn. method and pharmaceutical compsns. contg. same |
| 12/07/2005 | CN1230444C Use of HIV polypeptide or peptide or polynucleotide expression construct containing HIV-cell toxicant T-lymphocyte epitope |
| 12/07/2005 | CN1230439C Cisplatinun dinuclear platinum complex for treating cancer and its therapeutic method |
| 12/07/2005 | CN1230436C Imidazo[1,5,-a] pyrimido[5,4-d]benzazepine derivatives as GABAA receptor modulators |
| 12/07/2005 | CN1230434C Indazolyl-substituted pyrroline compounds as kinase inhibitor |
| 12/07/2005 | CN1230433C Cyclic AMP-specific phosphodiesterase inhibitors |
| 12/07/2005 | CN1230432C Substituted phenyl-Piperazine derivatives, their preparation and use |
| 12/07/2005 | CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors |
| 12/07/2005 | CN1230423C 1,4-disubstituted piperazine derivatives useful as uro-selective dollar g(a)1-adrenoceptor blockers |
| 12/07/2005 | CN1230421C Amide compounds and medicinal use thereof |
| 12/07/2005 | CN1230418C Selective androgen receptor modulators and methods of use thereof |
| 12/07/2005 | CN1230416C Pharmaceutical compounds |
| 12/07/2005 | CN1230212C Treatment of inflammatory disorders of the bowel and urinary bladder |
| 12/07/2005 | CN1230199C Use of nitric oxide for treatment of airway constriction |
| 12/07/2005 | CN1230198C Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having G chronic hepatitis C infection |
| 12/07/2005 | CN1230180C External medicine for killing and inhibiting fungus |
| 12/07/2005 | CN1230179C Micronized eplerenone compositions |
| 12/07/2005 | CN1230178C Remedies for bladder irritation signs in association with prostatauxe |
| 12/07/2005 | CN1230177C Water solution of penciclovir, and its prepn. method |
| 12/07/2005 | CN1230176C Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno[2,3-D] pyrimidine for treatment of pain |
| 12/07/2005 | CN1230175C Ligustrazine hydrochloride freeze-dried preparation for injection and its preparing method |
| 12/07/2005 | CN1230174C Selective iGLuR5 receptor antagonists for the treatment of migraine |
| 12/07/2005 | CN1230173C Preventives and remedies for complications of diabetes |
| 12/07/2005 | CN1230172C Blood circulation improving agent |
| 12/07/2005 | CN1230171C Treating diabetes by thiazolidine-diketo and dimethylbiguanide |
| 12/07/2005 | CN1230170C Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives |
| 12/07/2005 | CN1230169C Use of cyclopamine in the treatment of psoriasis |
| 12/07/2005 | CN1230168C Agent with an antidepressive effect |
| 12/07/2005 | CN1230167C Dual-release compositions of cyclooxygenase-2-inhibitor |
| 12/07/2005 | CN1230166C Gyrase inhibitors and uses thereof |
| 12/07/2005 | CN1230165C Azolylcarbynol derivatives of aryl (or heteroaryl) for treatment of respiratory diseases |
| 12/07/2005 | CN1230164C Combinations of(S)-2-(benzylamino-methyl)-2,3,8,9-tetrahydro-7H-1,4-dioxion[2,3-e]indol-8-one and neuroleptics |
| 12/07/2005 | CN1230163C 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens |
| 12/07/2005 | CN1230162C Pharmaceutical composition for modified release of an insulin sensitizing agent and another antidiabetic agent |
| 12/07/2005 | CN1230161C Persimmon leaf extract and its preparation and its usage |
| 12/07/2005 | CN1230160C Application of bamboo leaf total flavone in medicine for treating and preventing prostate disease |
| 12/07/2005 | CN1230159C Essential fatty acids in prevention of cardiovascular events |
| 12/07/2005 | CN1230158C Mixture of primary fatty acids obtained from sugar can wax and pharmaceutical use thereof |
| 12/07/2005 | CN1230157C Application of saccinic acid in preparing antianxiety medicine |
| 12/07/2005 | CN1230156C Fibrauretine dispersant tablet and its preparing method |
| 12/07/2005 | CN1230154C Sustained release compositions and a method of preparing pharmaceutical compositions |
| 12/07/2005 | CN1230148C Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology |
| 12/07/2005 | CN1230131C Therapeutic use of polymers |
| 12/07/2005 | CA2469339A1 Sustained release propafenone hydrochloride capsules |
| 12/07/2005 | CA2469327A1 Propafenone hydrochloride capsules containing microtablets |